Cargando…

The TRIAGE-ProADM Score for an Early Risk Stratification of Medical Patients in the Emergency Department - Development Based on a Multi-National, Prospective, Observational Study

INTRODUCTION: The inflammatory biomarker pro-adrenomedullin (ProADM) provides additional prognostic information for the risk stratification of general medical emergency department (ED) patients. The aim of this analysis was to develop a triage algorithm for improved prognostication and later use in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kutz, Alexander, Hausfater, Pierre, Amin, Devendra, Amin, Adina, Canavaggio, Pauline, Sauvin, Gabrielle, Bernard, Maguy, Conca, Antoinette, Haubitz, Sebastian, Struja, Tristan, Huber, Andreas, Mueller, Beat, Schuetz, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179054/ https://www.ncbi.nlm.nih.gov/pubmed/28005916 http://dx.doi.org/10.1371/journal.pone.0168076

Ejemplares similares

Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study
por: Schuetz, Philipp, et al.
Publicado: (2015)

Predictors for Delayed Emergency Department Care in Medical Patients with Acute Infections – An International Prospective Observational Study
por: Kutz, Alexander, et al.
Publicado: (2016)

Combination of the National Early Warning Score (NEWS) and inflammatory biomarkers for early risk stratification in emergency department patients: results of a multinational, observational study
por: Eckart, Andreas, et al.
Publicado: (2019)

Optimizing triage and hospitalization in adult general medical emergency patients: the triage project
por: Schuetz, Philipp, et al.
Publicado: (2013)

Role of MR-proADM in the risk stratification of COVID-19 patients assessed at the triage of the Emergency Department
por: Minieri, Marilena, et al.
Publicado: (2021)

Predictive Value of MR-proADM in the Risk Stratification and in the Adequate Care Setting of COVID-19 Patients Assessed at the Triage of the Emergency Department
por: Minieri, Marilena, et al.
Publicado: (2022)

MR-proADM as prognostic factor of outcome in COVID-19 patients
por: Sozio, Emanuela, et al.
Publicado: (2021)

MR-proADM as Prognostic Factor of Outcome in COVID-19 Patients
por: Cameli, Paolo, et al.
Publicado: (2023)

Comparative quality measures of emergency care: an outcome cockpit proposal to survey clinical processes in real life
por: Burgemeister, Susanne, et al.
Publicado: (2017)

Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
por: García de Guadiana-Romualdo, Luis, et al.
Publicado: (2021)

Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM
por: Then, Cornelia, et al.
Publicado: (2016)

MR-proADM and MR-proANP levels in patients with acute pulmonary embolism
por: Öner, Önsel, et al.
Publicado: (2020)

Improving the post-acute care discharge score (PACD) by adding patients’ self-care abilities: A prospective cohort study
por: Koch, Daniel, et al.
Publicado: (2019)

The Manchester Triage System in optimizing triage in adult general medical emergency patients: the Triage Project
por: Steiner, D, et al.
Publicado: (2014)

Application of MR-ProADM to predict prevention of hospitalisation, derived from a multi-centre study
por: Cullinan, Milo, et al.
Publicado: (2019)

Validation of the hospital frailty risk score in a tertiary care hospital in Switzerland: results of a prospective, observational study
por: Eckart, Andreas, et al.
Publicado: (2019)

Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
por: Önal, Uğur, et al.
Publicado: (2018)

The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections
por: Baumann, Philipp, et al.
Publicado: (2022)

Self-Care Index and Post-Acute Care Discharge Score to Predict Discharge Destination of Adult Medical Inpatients: Protocol for a Multicenter Validation Study
por: Conca, Antoinette, et al.
Publicado: (2021)

1542. MR-proADM Biomarker Predicts COVID-19 Clinical Outcomes: a US-based Cohort Study
por: Mansour, Michael
Publicado: (2022)

Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease
por: Struja, Tristan, et al.
Publicado: (2017)

Comparison of Cardiovascular Procedure Rates in Patients With Supplementary vs Basic Insurance in Switzerland
por: Struja, Tristan, et al.
Publicado: (2023)

Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score
por: Travaglino, Francesco, et al.
Publicado: (2012)

Metabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study
por: Struja, Tristan, et al.
Publicado: (2018)

Clinical scores and blood biomarkers for Prediction of bacteremia in emergency department patients: Bacteremia Assessment in Clinical Triage (BACT) study
por: Laukemann, S, et al.
Publicado: (2015)

Acute exacerbations of copd (AECOPD) in the emergency room (ER): prognostic value of proadrenomedulline (PROADM)
por: Dres, M, et al.
Publicado: (2015)

Procalcitonin Improves the Glasgow Prognostic Score for Outcome Prediction in Emergency Patients with Cancer: A Cohort Study
por: Rast, Anna Christina, et al.
Publicado: (2015)

Call, chosen, HA(2)T(2), ANDC: validation of four severity scores in COVID-19 patients
por: Wolfisberg, Selina, et al.
Publicado: (2021)

Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study
por: Vigué, Bernard, et al.
Publicado: (2016)

Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis
por: Liu, Dan, et al.
Publicado: (2016)

Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control
por: Iwao, Motoshi, et al.
Publicado: (2021)

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study
por: Gar, Christina, et al.
Publicado: (2022)

Mid-Regional Proadrenomedullin (MR-proADM) and Microcirculation in Monitoring Organ Dysfunction of Critical Care Patients With Infection: A Prospective Observational Pilot Study
por: Domizi, Roberta, et al.
Publicado: (2021)

Peripheral monocytosis as a predictive factor for adverse outcome in the emergency department: Survey based on a register study
por: Hensel, Mathias, et al.
Publicado: (2017)

Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium
por: Sujana, Chaterina, et al.
Publicado: (2022)

Risk assessment of sepsis through measurement of proAVP (copeptin): a secondary analysis of the TRIAGE study
por: Kloter, Milena, et al.
Publicado: (2021)

Comparison of Five TSH-Receptor Antibody Assays in Graves’ disease: results from an observational pilot study
por: Struja, Tristan, et al.
Publicado: (2019)

Psychological distress in medical patients 30 days following an emergency department admission: results from a prospective, observational study
por: Faessler, Lukas, et al.
Publicado: (2016)

Response to: MR-proADM has a good ability to predict mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders!
por: van Oers, Jos A.H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0bpljfqh8b85ug00b21ft35arq